Clinical Trial Update: Dexmedetomidine in Attenuation of Haemodynamic Response to Laryngoscopy in Controlled Hypertensive Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating dexmedetomidine to attenuate haemodynamic responses to laryngoscopy in controlled hypertensive patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia
• Hemodynamic Response
• Hypertension

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Sindh Institute of Urology and Transplantation | Conditions: Hypertension, Hemodynamic Response | Phase 3 | Status: COMPLETED